chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I tested positive for Covid 19 on 1Feb22.; I tested positive for Covid 19 on 1Feb22.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 26Mar2021 (Lot number: EP6955) at the age of 50 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "HTN" (unspecified if ongoing); "HLD" (unspecified if ongoing); "Sleep apnea" (unspecified if ongoing). Concomitant medication(s) included: ROSUVASTATIN; PANTOPRAZOLE; TRIAMTERENE HYDROCHLORIDE. Vaccination history included: Bnt162b2 (Dose: 1, Batch/Lot No: EL3248, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 05Mar2021, when the patient was 49 years old, for COVID-19 immunization. The following information was reported: COVID-19 (medically significant) with onset 01Feb2022, outcome "recovering", VACCINATION FAILURE (medically significant) with onset 02Feb2022, outcome "recovering" and all described as "I tested positive for Covid 19 on 1Feb22.". The event "i tested positive for covid 19 on 1feb22." and "i tested positive for covid 19 on 1feb22." was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Sep2021) negative; (01Feb2022) positive. Therapeutic measures were taken as a result of covid-19, vaccination failure. Fluticasone propionate (nasal spray), drink fluids, rest were taken as treatment.  No follow-up attempts are possible. No further information is expected.
strong chills, cold, sleeping and unable to stay awake. No fever but chills and felt like was in a refrigerator.  Lasted until approximately Noon on 2/5/2021
sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation. Concomitant products included RIVAROXABAN (XARELTO) for Atrial fibrillation.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       They did not want to stay on the phone to give more details. No treatment details reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-035979 (E2B Linked Report).   Reporter did not allow further contact
increased bilateral tinnitus; sensation of aural fullness/increased aural fullness; sensation of aural fullness/increased aural fullness; This is a spontaneous report from a contactable physician (Patient) reported in response to HCP letter sent in a cross-reference case which included that. A 58-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EK9231, Expiry date was not reported), via intramuscular route of administration on 30Dec2020 08:30 (age at the time of vaccination was 58-year-old) in Deltoid Left as dose 1, single for COVID-19 immunization. The Patient's medical history included rhinitis allergic from an unknown date and unknown if ongoing, pain from an unknown date and unknown if ongoing. Concomitant medication(s) included loratadine (LORATADINE) taken 10 mg daily as needed for rhinitis allergic, start and stop date were not reported; paracetamol (TYLENOL) taken 500-1000 mg once a day as needed for pain, start and stop date were not reported. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Prior vaccination (within 4 weeks) was not applicable and AE following prior vaccinations was none. Family Medical History Relevant to AE was not applicable. On 01Jan2021 08:00, the patient experienced increased bilateral tinnitus, sensation of aural fullness/increased aural fullness (ear discomfort), sensation of aural fullness/increased aural fullness (condition aggravated), mild-moderate, lasting several days. Causal Relationship was there a reasonable possibility that the event is related to suspect products yes. The patient was not visited to emergency room. The patient visited physician office and received treatments for the events. The outcome for the event increased bilateral tinnitus was not recovered and event sensation of aural fullness/increased aural fullness (ear discomfort) was unknown and event sensation of aural fullness/increased aural fullness (condition aggravated) was recovered on 06Jan2021.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Patient 16 y.o. at the time of vaccination, has no pertinent allergies or relevant hx. Patient received dose #1 of the Pfizer monovalent series (Lot #EW0167) 0.3 mL IM to the right arm at Store on 4/26/21 without issue. Patient received dose #2 of the Pfizer monovalent series (Lot #EW0168) 0.3 mL IM to the right arm at Store on 5/19/21. At an unknown time lapse from the second dose administration the patient experienced generalized urticaria (location unknown). The patient followed up with PCP, CRNP, at Medical Group regarding urticaria on 5/25/21; it is unknown what treatment/care patient received for the reaction but hives resolved. At an unknown time following the second dose administration patient also developed a cough with SOB for which she went to an urgent care and received a 5 day steroid course; the cough and SOB resolved.
Friday until current pain at injection site with soreness throughout shoulder. Saturday morning till current swelling of lymph nodes from left shoulder to midline of neck.
This case was reported by a consumer via call center representative and described the occurrence of Suspected vaccination failure in a 58-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. The patient's past medical history included shingles (since the age of 30 experienced shingles at the base of spine and or just about the buttocks). On an unknown date, the patient received the 1st dose of SHINGRIX and the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and SHINGRIX, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to SHINGRIX and SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported, but it could be 57 or 58 years. The patient took 2 rounds of the SHINGRIX vaccine and it helped a lot at the first but at the time of reporting it was not as much about half a year later. Initially the patient thought he was cured but of recent they seem to return almost as much as before receiving the vaccine, but with a shortened time to heal. The shingles popped out after long drives or lots of bending while working. The patient asked whether there was any need for a 3rd round of SHINGRIX that might boost the first two doses or would it be a waste of time and money and or cause a possible reaction. This case was considered as suspected vaccination failure as laboratory confirmation for shingles was not provided at the time of reporting.
About 2 weeks after my second dose of Moderna, I experienced sudden supraventricular tachycardia while I was at work on 02/12/2021.  I was taken to the ER where I was cardioverted with Adenosine.  I was sent home from the ER, however, I developed chest pain, heart palpitation, shortness of breath on exertion, and elevated heart rate that persisted for about 2 more weeks.  I had multiple visits with my doctor and a series of blood tests, EKGs s and an echocardiogram.
Tiredness; Headache; Fever up to 101.3; Chills; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Apr2021 at 14:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient did not receive any concomitant medication. The patient had no known allergies. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 08:45 (18 hours after receiving the vaccine), the patient experienced fever up to 101.3 and chills, which lasted for 24 hours. On 12Apr2021 at 13:00, the patient experienced tiredness and headache, which lasted more than 48 hours. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were taken as a result of events fever up to 101.3 (unspecified unit), chills, tiredness and headache and included treatment with homeopathic (herbal teas), vitamin c and advair from an unknown date. The clinical outcome of the event fever up to 101.3 and chills was recovered on 13Apr2021 after the duration of 1 day. The clinical outcome of the event tiredness and headache was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
R upper arm 4x6cm area erythema, edema, warmth, tender.
Vail was stored in the fridge approximately 26/11/21 or 16/12/21; Administered expired Moderna Covid-19 vaccine to several patients.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna Covid-19 vaccine to several patients.) and PRODUCT STORAGE ERROR (Vail was stored in the fridge approximately 26/11/21 or 16/12/21) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna Covid-19 vaccine to several patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vail was stored in the fridge approximately 26/11/21 or 16/12/21). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna Covid-19 vaccine to several patients.) and PRODUCT STORAGE ERROR (Vail was stored in the fridge approximately 26/11/21 or 16/12/21) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  It was reported that there were no temperature excursion.  Treatment information was not reported.
fatigue for a few days.  She went to Urgent care on 4/24 where she tested (+) for COVID.  Went to hospital April 29 evening around 10pm.  Discharged on April 30th around 500pm.  Diagnosed with pneumonia.
Reaction: Body aches and joint pain. Fatigue headache, fever. Ongoing joint pain and swelling, neuropathy pain in feet, sensation of aching in your foot pad on the both sides, more on the right side, Ongoing fatigue since after the 1st vaccine. Mild muscle aches in my legs. Always on this right leg, I've noticed that I'm weaker on my right leg and what I'm presuming is muscle pain that starts fairly immediately if my R leg is primary supporting me for whatever activity. This has been ongoing since the first vaccine. Painful, weaker. Never experienced this before in my life. Got home and felt okay, the fatigue started at the same time from the first vaccine. The symptoms that I experienced started at the same time as the first vaccine, meaning the same time of day (ex: 10PM for the first vaccine, 10PM for the 2nd vaccine when symptoms started). Must be a body clock situation. I did not get a fever the first night. Woke up feeling pretty great the next day but got a fever that late afternoon on the 2nd day. Hair fell out a bit after the 2nd dose as well (more during in 1st vaccine). Soreness at the injection site. Again not sure if this is in relation to the vaccine: Starting after 1st dose and still happening after the 2nd dose. A strange increase in mole activity. Strange eczema. Moles would appear and disappear. Most of them are all located in my region of my forehead and hairline. Not all of them, but most of them are there. None of this did I experience prior to the vaccine. Note: Previous COVID infection a year & 3 months ago. Severe case of COVID. Unsure if some of this is in relation to the vaccine or COVID itself. 1st vaccine add-ons: The day when I got out of bed after the first hallucinatory moment- I would get out of bed and when I stood, I would literally start to fall to left for 3-4 days. Couple nights of leg aching. Loss of balance. It's hard to describe. My body was on a ship and I would get up and go to the bathroom at 6AM and my body would just go to the left and I would have something to support me. I would finally be able to stabilize myself and it would happen every time. Neurological check-up indicated that when I stood on my right leg with eyes closed, I would fall over. This all happened after the first dose. Hair fell out a little bit after the 1st vaccine for one month.
PER PATIENT- AFTER SHE LEFT THE STORE SHE FELT DIZZINESS, RAPID HEARTRATE, ESOPHAGUS  STIFFENED UP, NAUSEA, SWEATING, CLAMMY
TDAP give 11/17/10. Pt c/o nausea with vomiting 11/18/10. Improved with only slight nausea 11/19/10 & able to eat ad lib.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history and concomitant medications were not reported. The nurse reported that since 19-NOV-2015 unspecified number of patients were vaccinated with improperly stored PROQUAD (Merck) (lot # L030585, expiry date 10-FEB-2017). The temperature excursion was at -5C for 16 hours and -10C for 15 hours and administered to the patient with in a time frame of 1 hour 3 minutes. No adverse effect reported. No further information was provided. No product quality complaint (PQC) was involved. This is one of the two cases received from the same reporter. Additional information has been requested.
Admitted to ED with COVID-19 and later some difficulty breathing.  Pt on RA. Given IC antibiotics, Ancef.  Discharged to Home. Treated conservatively as he is asymptomatic.
My lymph nodes in my left armpit swelled to the size of a small orange and there was pain and sensitivity there.  I iced the area and rested for two days.  I called our teledoc to see if this was an emergency.  The swelling was going down, but it was still painful after a few days.   They suggested to get a mammogram as well, but with the swelling going down it may be my lymph nodes doing what they are supposed to do.  I also developed a bright red patch on my left wrist and mid chest that was itchy.
Patient woke up on 2/19/21 without the ability to verbalize to her husband.  No other significant symptoms reported.  Husband took her to the hospital and they admitted her.  She stayed one night and was discharged the next day on 2/20/21 with complete resolution of the symptoms.
My arm was sore   Still is right now.  At about 10 pm last night I got ?the chills?
A non-serious report of FLUMIST administered 1 day beyond 48 hr recommended time frame of use was received from a health professional concerning a five-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. On 02-Nov-2011, the patient received FLUMIST vaccines exposed to 14 degree C one day beyond the 48 hour recommended time frame of use. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Information has been received from a nurse practitioner concerning a 23 year old female who on 26-FEB-2007 was vaccinated with the first dose Gardasil. On 20-MAR-2008, the patient was vaccinated with the second dose of Gardasil. The patient experienced arm pain at the injection site for one month after the first dose. It is unknown whether medical attention was sought. Patient was recovered from arm pain after a month. No product quality complaint was involved. Additional information has been requested.
Information has been received from a consumer concerning his 72 year old wife with rheumatoid arthritis and morphine allergy (rash), soma allergy (unspecified reaction) and TOLECTIN allergy (unspecified reaction) who on approximately 01-DEC-2009 ("about 4 months ago") was vaccinated with a dose of ZOSTAVAX (Merck) (lot# not reported). Concomitant therapy included methotrexate, prednisone and propranolol HCl and "several other unspecified medications". On approximately 31-JAN-2010 ("about two months after receiving vaccine"), the patient developed an ear ache, shingles and BELLs Palsy and was hospitalized. It was stated that "wife first experienced an ear ache in her left ear, then developed shingles on the left side of her face, and then developed BELLs Palsy that was affecting the left side of her face after receiving ZOSTAVAX (Merck)". "Blood work" was performed with no results reported. The patient was hospitalized for 4-5 days. At the time of this report, the patient had not recovered. No further information is available.
pt recvd DTP/MMR approx 1 wk p/immun pt exp vitiligo; reporting MD is not the vaccinator & is unable to identify DTP/MMR inject sites;
Information has been received from a pharmacist concerning a patient who in October or November 2007 was vaccinated intramuscularly with a dose of ZOSTAVAX (Oka/Merck). Subsequently, the patient developed an itch that lasted for 2 days. Medical attention was sought at the pharmacy. On an unspecified date the patient recovered from the itch. No product quality complaint was involved. Follow-up has been received from the pharmacist who stated that a 76-year-old male patient was vaccinated at 2 PM on 26-Oct-2007, intramuscularly in the deltoid with a first dose of ZOSTAVAX (Oka/Merck) (lot#658395/0966U). No medical attention was sought. This is one of several reports from the same reporter. Additional information is not expected.
patient in due to having a swollen arm from the vaccines given on 11/5/19, pt mother stated she noticed redness yesterday and it was more red and swollen yesterday as well, visual exam done pt left arm is warm to touch, hard with redness and raised, pt states it does not hurt. Nurse and I reassured mother it is normal localized reaction from mostly the DTAP vaccine and to continue with warm compress and to give child Tylenol/ibuprofen if he starts to complain of discomfort. Measured the redness of patient arm it is 10 cm in width  and 17cm in length informed pt to take patient to pediatrician if it spreads or discoloration appears.
Information has been received from a pharmacist regarding a patient of unknown age and gender. The patient's medical history or concurrent conditions were not provided. On 21-DEC-2012, the patient was vaccinated with a dose of (Merck) VARIVAX, dose, route and lot number were not provided. On an unknown date, the patient experienced headaches. The outcome of headache was unknown. This was originally reported by a pharmacist. Additional information is not expected.
Shortly after vaccination the left thigh significantly swollen with some mottled redness. The left thigh measured 35 cm while the right high measured 32.5 cm. The child was treated with some BENADRYL and oral prednisolone. After 24 hours of medication the swelling and redness significantly decreased. Mother states she noticed these lesions on both of his feet and legs since yesterday, 3/20, also states its on his hand. Mother states he has had these before when he had ant bites, but has not recently gone outside. Denies: Itching, Fever, Headache, Myalgia.
Initial and follow up information has been received from a physician concerning a 63 year old female admissions representative with no known drug allergies who on the morning of 7/28/05 wad inadvertently vaccinated IM in the left deltoid with a second 0.5ml dose of Pneumococcal 23v polysaccharide vaccine 650452/0753P. Concomitant therapy included simvastatin, lisinopril, aspirin, acebutolol, Brompheniramine maleate pseudoephedrine Lorane, hydrochlorothiazide manufacturer unknown, and glucosamine. Subsequently the office realized that she already received a dose of Pneumococcal 23v polysaccharide vaccine in Jan 2005 date note specified. Upon follow up received from the physician it was reported that on 7/28/2005 at approximately 9:30pm, the patient developed a fever up to 101 deg F and was swollen and tender to touch. There was no illness at the time of vaccination. The patient was reported to have recovered on 7/29/05. There was no product quality complaint involved. Additional information is not expected.
Reported fever of 100.6-101, fatigue,headache, muscle ache. Resolved with rest.